Literature DB >> 15241548

Lipopolysaccharide-binding molecules: transporters, blockers and sensors.

R Chaby1.   

Abstract

Lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria, can be beneficial to the host by activating the innate immune system, or harmful, by inducing inflammation, disseminated intravascular coagulation, multiple organ failure, shock and often death. On the bacteria, and in host biological fluids and cells, LPS is never free but constantly attached to cognate-binding proteins. Understanding how LPS is transported and further recognized by sensors able to deliver a signal, or by inactivating molecules able to neutralize its biological effects, is an important goal. This review describes the large panel of peptides and proteins reported to associate with LPS, and provides information on their origin, their structure and the location of amino acid residues involved in their interaction with LPS. A better understanding of the mode of recognition of LPS by cognate proteins prompted many laboratories to design on a rational basis synthetic molecules which can be used to detect low amounts of endotoxin, or to act as efficient blockers of in vitro and in vivo responses to LPS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241548     DOI: 10.1007/s00018-004-4020-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  18 in total

1.  Lactosomes: structural and compositional classification of unique nanometer-sized protein lipid particles of human milk.

Authors:  Nurit Argov-Argaman; Jennifer T Smilowitz; Daniel A Bricarello; Mariana Barboza; Larry Lerno; John W Froehlich; Hyeyoung Lee; Angela M Zivkovic; Danielle G Lemay; Samara Freeman; Carlito B Lebrilla; Atul N Parikh; J Bruce German
Journal:  J Agric Food Chem       Date:  2010-10-06       Impact factor: 5.279

Review 2.  A tug-of-war between the host and the pathogen generates strategic hotspots for the development of novel therapeutic interventions against infectious diseases.

Authors:  Aarti Rana; Mushtaq Ahmed; Abdur Rub; Yusuf Akhter
Journal:  Virulence       Date:  2015-06-24       Impact factor: 5.882

3.  Llama single-chain antibody that blocks lipopolysaccharide binding and signaling: prospects for therapeutic applications.

Authors:  Mohamed El Khattabi; Hendrik Adams; Erik Heezius; Pim Hermans; Frank Detmers; Bram Maassen; Peter van der Ley; Jan Tommassen; Theo Verrips; Jord Stam
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

4.  Anti-lipopolysaccharide factors in the American lobster Homarus americanus: molecular characterization and transcriptional response to Vibrio fluvialis challenge.

Authors:  K M Beale; D W Towle; N Jayasundara; C M Smith; J D Shields; H J Small; S J Greenwood
Journal:  Comp Biochem Physiol Part D Genomics Proteomics       Date:  2008-12       Impact factor: 2.674

5.  Fold-unfold transitions in the selectivity and mechanism of action of the N-terminal fragment of the bactericidal/permeability-increasing protein (rBPI(21)).

Authors:  Marco M Domingues; Sílvia C D N Lopes; Nuno C Santos; Alexandre Quintas; Miguel A R B Castanho
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

6.  A novel ML protein from Manduca sexta may function as a key accessory protein for lipopolysaccharide signaling.

Authors:  Jing-qun Ao; Erjun Ling; Xiang-jun Rao; Xiao-Qiang Yu
Journal:  Mol Immunol       Date:  2008-03-17       Impact factor: 4.407

7.  Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.

Authors:  Nicolas Guyot; Marcus W Butler; Paul McNally; Sinead Weldon; Catherine M Greene; Rodney L Levine; Shane J O'Neill; Clifford C Taggart; Noel G McElvaney
Journal:  J Biol Chem       Date:  2008-09-17       Impact factor: 5.157

Review 8.  Chapter 2: Kill the bacteria...and also their messengers?

Authors:  Robert Munford; Mingfang Lu; Alan Varley
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

9.  Effects of palmitoylation on dynamics and phospholipid-bilayer-perturbing properties of the N-terminal segment of pulmonary surfactant protein SP-C as shown by 2H-NMR.

Authors:  Azucena Gonzalez-Horta; David Andreu; Michael R Morrow; Jesús Perez-Gil
Journal:  Biophys J       Date:  2008-05-23       Impact factor: 4.033

10.  Naringin inhibits lipopolysaccharide-induced damage in human umbilical vein endothelial cells via attenuation of inflammation, apoptosis and MAPK pathways.

Authors:  Cheng Bi; Yinong Jiang; Tingting Fu; Yu Hao; Xifang Zhu; Yan Lu
Journal:  Cytotechnology       Date:  2016-03-23       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.